Sarasota, FL -- (SBWIRE) -- 04/19/2019 -- Zion Market Research has published a new report titled "Regenerative Medicines Market by Therapy (Tissue Engineering, Cell Therapy, Immunotherapy, and Gene Therapy), by Material (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials, and Others), and by Application (Oncology, Orthopedic and Musculoskeletal Spine, Cardiovascular, Dermatology, Central Nervous System, Diabetes, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024". According to the report, global regenerative medicines market was valued at approximately USD 7.97 billion in 2017 and is expected to generate revenue of around USD 26.30 billion by the end of 2024, growing at a CAGR of around 18.59% between 2017 and 2024.

Regenerative medicines include the process of regenerating human cells, organs, and tissues to restore its normal function. They have the capability to regenerate damaged tissues and whole organ by replacing damaged tissue and organ. Sometimes, regenerative medicines also stimulate the repair mechanism of the body to heal its organ or tissue. Scientists use this to grow tissues and organs in the laboratory to implant them in the body when it is unable to heal itself.

Request Free Sample Report of Regenerative Medicines Market Report @ https://www.zionmarketresearch.com/sample/regenerative-medicines-market

The global regenerative medicines market is segregated on the basis of therapy, material, and application. On the basis of therapy, the market is segmented into tissue engineering, cell therapy, immunotherapy, and gene therapy. Cell therapy segment is expected to dominate the regenerative medicines market due to its rapid growth in the use of stem cells for grafting and organ generation techniques. The materials segment is divided into synthetic materials, biologically derived materials, genetically engineered materials, and others. Biologically derived materials are expected to dominate the regenerative medicines market but genetically engineered materials are expected to show high growth due to increase in the use of various genetic engineering techniques such as gene sequencing and editing technology. The application segment includes oncology, orthopedic and musculoskeletal spine, cardiovascular, dermatology, central nervous system, diabetes, and other applications. Dermatology segment is expected to dominate the regenerative medicines market due to the use of various stem cells in injuries and chronic wounds.

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the regional segments of global regenerative medicines market. North America is anticipated to remain the leading region over the forecast period due to the increase in awareness about the regenerative medicines among the population and technological developments in this sector. Europe is expected to show a significant growth in the forecast period due to growing prevalence of various diseases such as bone and joint diseases, diabetes, cancer, etc., in which regenerative medicines are used as a cure. Rise in awareness about health, investment in research of regenerative medicine, and growing healthcare expenditure are some of the major factors which are expected to fuel the growth of the regenerative medicines market in the Asia Pacific. Latin America and the Middle East & Africa are also expected to show a steady growth in the forecast period.

Download Free PDF Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/regenerative-medicines-market

The key players in the global regenerative medicines market are Acelity, Celgene Corporation, NuVasive, Inc., Vericel Corporation (Genzyme), StemCells, Inc., Japan Tissue Engineering Co., Ltd., Anika Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Inc., Medtronic, Inc., and Arthrex, Inc. The players are frequently involved in developing new therapies in regenerative medicines.

This report segments the global regenerative medicines market as follows:

Global Regenerative Medicines Market: Therapy Segment Analysis

Tissue Engineering
Cell Therapy
Immunotherapy
Gene Therapy

Global Regenerative Medicines Market: Material Segment Analysis

Synthetic Materials
Biologically Derived Materials
Genetically Engineered Materials
Others

Global Regenerative Medicines Market: Application Segment Analysis

Oncology
Orthopedic and Musculoskeletal Spine
Cardiovascular
Dermatology
Central Nervous System
Diabetes
Other Applications

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/regenerative-medicines-market

Global Regenerative Medicines Market: Regional Segment Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse New Press Release: https://www.zionmarketresearch.com/news/regenerative-medicines-industry

About Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.